Lykos Therapeutics Appoints Allison Rosenthal As Chief Commercial Officer and COY Stout As Vice President of Market Access
May 03, 2024•over 1 year ago
Position
Vice President
Company
Lykos Therapeutics
Description
Allison Rosenthal has been appointed as Chief Commercial Officer (CCO) and member of the Company's executive committee. Coy Stout has also joined as Vice President (VP) of Market Access. These appointments mark critical milestones as the company builds out its commercial organization and prepares for potential product launches.
FundzWatch™ Score
78
Medium Activity
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months